Correction: Clinical features and associated factors of intraocular inflammation following intravitreal brolucizumab as switching therapy for neovascular age‑related macular degeneration.

Autor: Sotani R; Division of Ophthalmology, Department of Surgery, Kobe University Graduate School of Medicine, 7‑5‑2, Kusunoki‑Cho, Chuo‑Ku, Kobe, 650‑0017, Japan., Matsumiya W; Division of Ophthalmology, Department of Surgery, Kobe University Graduate School of Medicine, 7‑5‑2, Kusunoki‑Cho, Chuo‑Ku, Kobe, 650‑0017, Japan. ytkmatsu@med.kobe-u.ac.jp., Kim KW; Division of Ophthalmology, Department of Surgery, Kobe University Graduate School of Medicine, 7‑5‑2, Kusunoki‑Cho, Chuo‑Ku, Kobe, 650‑0017, Japan., Miki A; Division of Ophthalmology, Department of Surgery, Kobe University Graduate School of Medicine, 7‑5‑2, Kusunoki‑Cho, Chuo‑Ku, Kobe, 650‑0017, Japan., Yasuda E; Department of Ophthalmology, Kakogawa Central City, Hospital, Kakogawa, Japan., Maeda Y; Department of Ophthalmology, Kakogawa Central City, Hospital, Kakogawa, Japan., Hara R; Department of Ophthalmology, Kakogawa Central City, Hospital, Kakogawa, Japan., Kusuhara S; Division of Ophthalmology, Department of Surgery, Kobe University Graduate School of Medicine, 7‑5‑2, Kusunoki‑Cho, Chuo‑Ku, Kobe, 650‑0017, Japan., Nakamura M; Division of Ophthalmology, Department of Surgery, Kobe University Graduate School of Medicine, 7‑5‑2, Kusunoki‑Cho, Chuo‑Ku, Kobe, 650‑0017, Japan.
Jazyk: angličtina
Zdroj: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie [Graefes Arch Clin Exp Ophthalmol] 2024 Feb; Vol. 262 (2), pp. 671.
DOI: 10.1007/s00417-023-06339-z
Databáze: MEDLINE
Externí odkaz: